Efficacy, safety and pharmacokinetics of subcutaneous azacitidine in Chinese patients with higher risk myelodysplastic syndromes: Results from a multicenter, single-arm, open-label phase 2 study

Author:

Du Xin1,Lai Yue-Yun2,Xiao Zhijian3,Liu Ting4,Hu Yu5,Sun Aining6,Li Xiao7,Shen Zhi-Xiang8,Jin Jie9,Yu Li10,Laille Eric11ORCID,Dong Qian11,Songer Stephen11,Beach C.L.11

Affiliation:

1. Department of Hematology; Guangdong General Hospital/Guangdong Academy of Medical Sciences; Guangdong General Hospital affiliated to South China University of Technology; Guangdong China

2. Peking University People's Hospital; Peking University Institute of Hematology; Beijing China

3. Institute of Hematology and Blood Diseases Hospital; Chinese Academy of Medical Sciences and Peking Union Medical College; Tianjin China

4. Department of Hematology; West China Hospital of Sichuan University; Chengdu China

5. Institute of Hematology; Union Hospital, Tongji Medical College; Huazhong University of Science and Technology; Wuhan China

6. Department of Hematology; First Affiliated Hospital of Soochow University; Suzhou China

7. Department of Hematology; Shanghai Sixth People's Hospital; Shanghai China

8. Department of Hematology; Ruijin Hospital; Shanghai China

9. Department of Hematology; First Affiliated Hospital of Zhejiang University College of Medicine; Zhejiang China

10. Department of Hematology; Chinese PLA General Hospital; Beijing China

11. Celgene Corporation; Summit NJ USA

Funder

Celgene

Publisher

Wiley

Subject

Oncology,General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3